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S _nnuay A panel of human colonic adenocarcinoma cell lines was examined both for expression of mRNAs
of the nitric oxide synthase (NOS) gene family and for evidence of enzymic activity based on citrulline and
nitrite (NO,-) formation. Reverse transcription-polymerase chain reaction (RT-PCR). revealed that all lines
(SW480. SW620. DLD-1 and WiDr) expressed mRNA for the Ca-+-dependent endothelial (e)NOS. while
SW480 cells also expressed the Ca2'-dependent neuronal (n)NOS. The mRNA for the Ca'+-independent
inducible (i)NOS was expressed both by cytokine-stimulated and by unstimulated SW480. SW620 and DLD-1
cells, but none was seen at any time in the WiDr cells. There was, however, little correlation between mRNA
expression and enzynic activity based on citruUline and NO,- formation. Thus none of the cell lines exhibited
measurable Ca'-dependent NOS activity, while Ca2'-independent NOS activity was seen in all but the WiDr
cells. Furthermore. DLD-1 cells generated citrulline with resultant NO.- formation only after stimulation with
lipopolysacchanrde (LPS) and or cytokines. while SW480 and SW620 did so constitutively. Thus RT-PCR
studies indicate that tumour cells of similar epithelial origin display a diverse pattern of NOS gene family
expression. and parallel biochemical studies clearly indicate that such expression does not always result in
measurable enzymic activity leading to the generation of NO.
Nitric oxide (NO) plays several important physiological roles
in the cardiovascular, nervous and immune systems (for
reviews see Nathan. 1992; Moncada & Higgs, 1993). NO is
synthesised from the amino acid L-arginine (Palmer et al..
1988) by a family of at least three enzymes, the nitnrc oxide
synthases (NOS). These include the constitutively expressed
eNOS from endothelium (Moncada, 1992) and brain-derived
neuronal or nNOS (Garthwaite et al., 1988), both of which
are Ca2'-dependent, and the Ca2'-independent, cytokine-
inducible iNOS isolated from murine macrophages (Stuehr &
Nathan, 1989). Induction of iNOS has now been reported in
human cells, including macrophages (Denis, 1991).
hepatocytes (Nussler et al., 1992), vascular smooth muscle
(Scott-Burden et al., 1992), megakaryoblasts (Lelchuk et al.,
1992), chondrocytes (Charles et al., 1993) and the human
colonic adenocarcinoma cell line, DLD-1 (Sherman et al..
1993). The Ca -independent NOS has also been demon-
strated in two other human colonic adenocarcinoma cell
lines, SW480 and SW620, but paradoxically in these the
enzyme appeared to be expressed constitutively (Radomski et
al., 1991). In order to examine the pattern of NO synthase
expression in a panel of human adenocarcinoma cell lines, we
have used a combined approach correlating enzyme activity,
as measured by citrulline formation and NO2- accumulation.
with NOS mRNA expression.
Materials and methods
Cell lines
Human tumour cell lines SW480, SW620, DLD-l and WiDr,
derived from primary or, in the case of SW620, metastatic
adenocarcinomas of the colon, were obtained from the
American Type Culture Collection (ATCC), Rockville, MD,
USA. In all experiments WiDr cells were cultured in Dulbec-
co's minimum essential medium (D-MEM), DLD-1 cells in
RPMI-1640 medium and SW480 and SW620 cells in
Liebovitz L-15 medium. All were supplemented with 10%
fetal calf serum (FCS), 0.5% pencillin/streptomycin solution
(10,000 units ml-') and 0.75% gentamicin, all obtained from
Gibco BRL, Paisley, UK. All were incubated at 37°C: WiDr
and DLD-1 cells in 5% carbon dioxide in air and SW480 and
SW620 cells in air phase only.
Culture conditionsfor assay ofconstitutive and induced NOS
Each cell line was seeded into Falcon tissue culture flasks at
a density of I x 10' cells per ml on day 0 and NOS activities
were measured 48 h later. In some experiments cells were
stimulated after 24 h with either lipopolysaccharide (LPS)
from Sabnonella typhosa (Difco Labs, Detroit. MI, USA) at
a concentration of 10 ng ml-1 plus interferon gamma (IFN-y)
(Genzyme, West Malling, UK) at 250 units ml-' or IFN-y
plus tumour necrosis factor (TNF-x) (British Biotechnology,
Abingdon, UK) at 250 and 100 units ml-' respectively. Dur-
ing LPS and/or cytokine stimulation, L-sepiapterim (Dr B.
Schirks Labs, Jona, Switzerland), a precursor of tetrahyd-
robiopterin, was also added at 10O JM after 24 h.
For subsequent molecular and biochemical analyses the
cells were removed from the flasks after trypsinisation and
pelleted by centrifugation at 450 g for 5 min. For the assay of
[U-`4CJcitrulline, soluble cytosolic cell fractions were prepared
after two cycles of freezing in liquid nitrogen followed by
thawing at 4°C. Samples of the medium used to culture the
cells were also removed for NO.- analysis by chemilumin-
escence.
AssaYs ofNOS activit}
NOS activity was determined by measuring the rate of con-
version of L-[U-'4C]arginine to [U-14Clcitrulline by soluble
cytosolic extracts of the cells (Radomski et al.. 1993). This
assay was carried out in the presence and absence of 1 mM
EGTA in order to distinguish between Ca2'-dependent and
Ca-+-independent activity. Results were expressed as pmol
mg-' protein min-'. Levels of NO2- in the medium used to
culture the cells were also determined by chemiluminescence
(Palmer et al.. 1987). and the amounts of NO.- detected
were expressed in JAM, after reference to an NO2- standard
curve. Data obtained from both assays are expressed as
mean ± s.e.m. These were subjected to analysis of variance
and P<0.05 was considered significant.
For the molecular detection of NOS. poly(A)+ mRNA was
isolated from WiDR, SW480. SW620 and DLD-1 cells using
Fast Track reagents (Invitrogen. San Diego. CA. USA).
Positive control poly(A)+ mRNA samples were isolated from
induced human chondrocytes as described previously
(Charles et al., 1993) and the human skeletal muscle and
placental mRNA was supplied by Clontech. Cambridge. UK.
RNA-PCR was performed using the Gene AMP RNA-
PCR kit (Perkin-Elmer Cetus, Beaconsfield, UK) following
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the manufacturer's recommended conditions. A total of 25 ng
of template RNA and 100 ng of each oligonucleotide primer
were used in the reactions. Specific primers were designed
and synthesised to distinguish between the different NOS
sequences. For iNOS (Charles et al., 1993) the sequences
were 5'-GCCTCGCTCTGGAAAGA-3' (bases 1,425-1,441,
sense) and 5'-TCCATGCAGACAACCTTl-3' (bases 1,908-
1,924, antisense), amplifying a 499 bp product. Sequences for
the constitutive eNOS (Janssens et al., 1992) were 5'-
GAAGAGGAAGGAGTCCAGTAACACAGAC-3' (bases
1,930-1,957, sense) and 5'-GGACTIGCTGCITTGCAG-
GTTTTC-3' (bases 2,345-2,368, antisense), amplifying a
438 bp product, and for constitutive nNOS (Nakane et al.,
1993) 5'-1TTCCGAAGCTTCTGGCAACAGCGGCAATT-3'
(bases 4,207-4,236, sense) and 5'-GGACTCAGATCTA-
AGGCGGTTGGTCACITC-3' (bases 4,649-4,678, anti-
sense), amplying a 471 bp product. The conditions for each
PCR were 96'C for 35 s, 56'C for 2 min, 72'C for 2 min in
the presence of 1 mM magnesium chloride for 35 or 55 cycles.
In all cases RNA samples were tested for their ability to
generate a PCR signal by using positive control P-actin
primers from Clontech, Cambridge, UK (data not shown). A
negative control, omitting reverse transcriptase, was carried
out for all PCRs.
Results
NOS activity in cell lines, as measured by the rate of conver-
sion of L-arginine to L-citrulline before and after treatment
with cytokines with or without LPS, is given in Table I.
SW480 cells constitutively expressed the iNOS and expression
was not significantly increased after treatment either with
LPS/IFN--y or with TNF-a/IFN--y. No enzyme activity was
seen in DLD-1 cells prior to induction, but incubation with
either LPS/IFN-y or TNF-m/IFN-y resulted in detectable
iNOS activity. Neither line showed any Ca"-dependent NOS
activity either before or after exposure to cytokines and/or
LPS, and neither Ca"+-dependent nor Ca"+-independent
NOS activity was seen at any time in the WiDr cells.
Corroboration of the above results was obtained when
concentrations of NO2- present in the medium used to cul-
ture these cells was measured by chemiluminescence (Table
II). In this case appreciable quantities of NO2- were
measured in the medium from both control and induced
SW480 cells and in the medium from induced DLD-1 cells,
but not in the medium from WiDr cells.
The results of analysis of NOS isozyme expression in
WiDr, SW480, SW620 and DLD-1 cells by RT-PCR are
given in Figures 1 and 2. For the WiDr, SW620 and DLD-l
Table I NOS activity, as measured by rate of conversion of
L-[4C]argine to L-f4C] citrulline, of three human colon
adenocrincoma cell lines before and after treatment with LPS/IFN-y
or TNF-a/IFN-y
Enzyme Enzyme activity
(pmol of citrulline mg-' protein min-'
[mean (s.em)J
Inducing agents WiDr DLD-1 SW48
Cal' k-dpendent
None ND ND ND
LPS/IFN-y ND ND ND
TNF-a/IFN-y ND ND ND
Ca` -independen
None ND ND 5.3 (005)b
LPS/IFN-y ND 3.2 (0.1) 5.3 (0.05)
TNF-a/IFN-7 ND 1.5 (0.12) 4.5 (0.08)
ND, not detectable: <0.1 pmol mg-' protein min-'. aPreviously
shown (Radomski et al., 1991) that SW620 cells showed
approximately 20% of that activity seen in SW480 ceUs. bPreviously
shown (M.W. Radomski, unpublshed) that his level of enzyme
activity in SW480 cels is not inhibited by I gum dexamethasone, an
inhibitor of iNOS expression (Radomski et al., 1990).
RNA samples the nNOS oligonucleotide primer set produced
no positive signal, indicating the absence of any neuronal
NOS mRNA from these cells. However, SW480 RNA gave a
faint but distinct band at a position identical to the human
skeletal muscle RNA in the control lane. When the iNOS
olignucleotide primer set was used, a strong band for the
499 bp product was seen in SW480 and a distinct but weaker
band in the SW620 samples after 55 cycles. This primer set
also generated a 499 bp product in DLD-l cells, and this was
obvious both before and after induction with IFN-y7NF-a.
No equivalent band was seen in any of the WiDr samples.
Interestingly, when the eNOS primer set was used, a strong
positive band was seen in all cell lines except DLD-1, in
which a distinct but much fainter band was seen.
Table H NOS activity, as indicated by levels of NO,- released into
culture medium by WiDr, DLD-1 and SW480 cells before and after
treatment either with LPSlIFN-y or TNF-a/zIFN-y
NO2- concentration (uM)
[mean and (s.e.m.)]
Inducing agents WiDR DLD-1 SW480
None ND ND 1.67 (0.20)
LPSiIFN--y ND 2.68 (0.58) 1.78 (0.18)
TNF-x/IFN-y ND 2.71 (0.62) 1.50 (0.27)
ND, not detectable: <0.2;LM.
a b
M 1 2 3 4 M M 1 2 3 4 M
c
M 1 2 3 4M
/ 1,018
_ 506/517
396
Fie 1 Analysis of NOS isozyme mRNA expression in WiDr,
SW480 and SW620 cells by RT-PCR. Thirty-five cycles of PCR
were performed and samples were run on a 1.5% agarose gel. a, b
and c show RT-PCR for eNOS, nNOS and iNOS respectively.
Markers (M) in base pairs are indicated. Tracks I are WiDr, 2
are SW480 and 3 are SW620. Tracks 4 are positive controls from
human placenta (a4), human skeletal muscle (64) and induced
human chondrocytes (c4). In a, positive 438 bp eNOS bands are
found in tracks 1, 2, 3 and 4. In b, a strongly positive 471 bp
nNOS band is found in control track 4 and a much weaker, but
nevertheless positive, nNOS band is also seen in track 2. In c,
track 2 and control track 4 have produced strong 499 bp iNOS
bands, while tracks I and 3 are negative. A positive 499 bp band
was obtained in track 3, however, when 55 cycles of PCR were
carried out (data not shown).
a
M 1 2 3 4 M
b
M 1 2 3 4 M
C
M 1 2 3 4 M
- 1,018
- 506/517
396
Fuwe 2 Analysis of NOS isozyme mRNA expression in DLD-1
cells by RT-PCR. a, b and c show RT-PCR of eNOS, nNOS
and iNOS respectively. Markers (M) in base pairs are indicated.
Tracks 1-3 are DLD-1 uninduced and cytokine-induced for 5
and 18 h respectively. Tracks 4 are positive controls from human
placenta (a4), human skeletal muscle (b4) and induced human
chondrocytes (c4). In a, faintly positive 438 bp eNOS bands are
found in tracks 1, 2 and 3 and a strongly positive control band is
found in track 4. In b a strongly positive 471 bp nNOS band is
found in control track 4, while tracks 1-3 are negative. In c, all
tracks, including track I (uninduced cells), have produced strong
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Biochemical analyses of a number of human colonic
adenocarcinoma cell lines have indicated that tumour cell
lines of similar epithelial origin exhibit very different patterns
of behaviour with regard to the endogenous generation of
NO. We have previously shown (Radomski et al., 1991) and,
in the case of SW480, confirm here that SW480 and SW620
constitutively express a Ca2+-independent NOS resulting in
the production of NO. DLD-1 (Sherman et al., 1993) also
produces NO, but only after the induction ofiNOS with LPS
and/or cytokines. WiDr cells, however, appear not to pro-
duce NO either before or after stimulation with a variety of
LPS/cytokine cocktails.
Molecular analysis of the NOS mRNAs from these lines
reveal a more complex picture. Interestingly, all lines con-
tained the Ca2"-dependent eNOS mRNA, though on North-
ern blot (data not shown) and biochemical evidence no
obvious RNA or active enzyme was present. SW480 also
contained nNOS mRNA, but again no evidence for any
Ca2'-dependent enzyme activity was obtained. The fact that
all but the WiDr ceUs also contained the iNOS mRNA is
consistent with the biochemical findings, in that iNOS
activity was seen in all lines except WiDr, which was negative
for enzyme activity and endogenous NO generation in all
experiments, Interestingly, DLD-1 ceUs contained iNOS
mRNA regardless of whether or not the ceUs had been
exposed to cytokines. In this case it would appear that small
amounts of RNA had been constitutively transcribed but
that active enzyme was present only after its induction by
LPS and/or cytokines.
The human colonic adenocarcinoma SW620 was included
in the molecular analyses because we had previously demon-
strated (Radomski et al., 1991) that this line, a metastatic
derivative of SW480, also produced NO constitutively from a
Ca2+-independent NOS. This RNA was present at a
significantly lower level than that found in SW480, which is
consistent with our previous observation that SW620 cells
produced smaller quantities of NO.
By correlating the presence of NOS mRNA as determined
by RT-PCR with the presence of NOS as determined by
enzymatic activity measurements, we have characterised the
pattern of NOS expression in a panel of human
adenocarinoma cell lines. Interestingly, this study has
confirmed that the inducible NOS gene may be expressed
constitutively in certain tumour cell lines. In addition, these
same cell lines may express multiple members of the NOS
gene family. With the increasing use of RT-PCR as a diag-
nostic technique on biopsy samples, this finding of multiple
expression may result in confused interpretation of the role
of NOS in tumour biology, unless the RT-PCR data are
supported by full characterisation of each NOS isozyme at
the molecular and biochemical levels for evidence for the
synthesis of NO.
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